Gelesis100 FDA Approval - Search Videos

FDA panel endorses generic drug for cancer patients

FDA panel endorses generic drug for cancer patients

FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis

FDA Approves Genentech’s Gazyva for the Treatment of Lupus Nephritis

businesswire.com

U.S. FDA Approves UroGen’s ZUSDURI™ (mitomycin) for Intravesical Solution as the First and Only Medication for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)

U.S. FDA Approves UroGen’s ZUSDURI™ (mitomycin) for Intravesical Solution as the First and Only Medication for Recurrent Low-Grade Intermediate-Risk Non-Muscle Invasive Bladder Cancer (LG-IR-NMIBC)

businesswire.com

FDA Approval Updates: Pfizer, Moderna, and Novavax COVID-19 Vaccine - GoodRx

FDA Approval Updates: Pfizer, Moderna, and Novavax COVID-19 Vaccine - GoodRx

FDA fast-tracks approval for Alzheimer's drug

FDA fast-tracks approval for Alzheimer's drug

FDA grants full approval to Pfizer vaccine

FDA grants full approval to Pfizer vaccine

Geron stock pops on FDA approval for blood cancer drug

Geron stock pops on FDA approval for blood cancer drug

FDA grants full approval to Pfizer Covid vaccine

Check Your Health: FDA gives full approval for COVID-19 vaccine

FDA grants full approval to Pfizer's Covid vaccine

NBC NewsSara G. Miller,Erika Edwards

🚨 FDA approval alert! The U.S. Food and Drug Administration has just granted accelerated approval to Emrelis (telisotuzumab vedotin-tllv) for certain people with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC), who have high c-MET protein over-expression and have previously received systemic therapy. This is big news for those whose tumors show high c-MET protein over-expression—a group with few treatment options. 🎯 Emrelis is a type of antibody-drug conjugate, d

379 viewsMay 16, 2025

FacebookGO2 for Lung Cancer

New Alzheimer’s drug Leqembi is granted full FDA approval

NBC NewsBerkeley Lovelace Jr.

Elon Musk's Neuralink wins FDA approval for human study of brain implants

ReutersRachael Levy,Marisa Taylor,Akriti Sharma

Vertex and CRISPR Therapeutics gain FDA approval for CASGEVY - World’s first sickle cell treatment using CRISPR gene editing technology

notebookcheck.net

Meet Elsa: FDA’s most advanced AI tool to streamline drug reviews

interestingengineering.com

FDA grants limited approval to new Covid vaccine from Moderna

NBC NewsAria Bendix

FDA approves Alzheimer's treatment

CBS NewsAlexander Tin

FDA approves a second Alzheimer's drug that can modestly slow disease

Compound versions of GLP-1 drugs for weight loss halted by FDA

Updated 2025 List of FDA-Approved Cell and Gene Therapies - The Niche

First over-the-counter birth control pill approved by FDA: What patients need to know

FDA approves cure for sickle cell disease, the first treatment to use gene-editing tool CRISPR

NBC NewsBerkeley Lovelace Jr.,Marina Kopf

Celcuity Says New Drug Application for Breast Cancer Treatment Accepted by FDA

marketscreener.com

FDA Approves Sotorasib Plus Panitumumab for KRAS G12C–Mutated Colorectal Cancer | OncLive

FDA Approves Luspatercept for First-line Treatment of Anemia in Lower-Risk MDS | OncLive

FDA approves Eli Lilly's GLP-1 pill, opening the next phase of the weight loss drug market

MSNAngelica Peebles

FDA confirms new trial endpoint for approval

theaustralian.com.au

⭐️ Update on HER2 Vaccine, GLSI-100, which has now received FDA fast track designation (which can lead to earlier drug approval). GLSI-100 is an experimental breast cancer vaccine being studied to help reduce the risk of HER2-positive breast cancer recurrence. It combines a small protein fragment called GP2, which comes from the HER2 protein, with GM-CSF, which stimulates antigen presenting cells. Together, they help the immune system recognize HER2 as a target and T cells can then destroy any r

5K views8 months ago

FacebookEleonora Teplinsky, MD

Tavapadon in Parkinson's disease: results from phase 3 studies.

7.1K views1 month ago

YouTubeDr. Rubens Cury

Greenwich LifeSciences GLSI Phase III Breast Cancer Therapy Update | RedChip Companies posted on the topic | LinkedIn

6.9K views4 months ago

See more